Amrize Ltd
AMRZ· NYSE
AMRZAmrize Ltd
Filed May 7, 2026 · 10-Q · 37 days after period end · 0002035989-26-000057
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $2.18B | $2.09B |
| Net Income | -$105.00M | -$94.00M |
| EPS Diluted | -$0.19 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amrize Ltd · CIK 2035989 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end
